Growth Hormone-secreting adenomas exhibits variable biological behavior and heterogeneous natural history, ranging from small adenomas and mild disease, to invasive and aggressive neoplasms with more severe clinical picture. Patients not cured or controlled after neurosurgical and first-generation somatostatin receptor ligands (SRL) therapy could require multiple surgical, medical and/or radiation treatments to achieve disease control. To date, no clinical, laboratory, histopathological, or neuroradiological markers are able to define the aggressiveness or predict the disease prognosis in patients with acromegaly. Therefore, the management of these patients requires careful evaluation of laboratory assessments, diagnostic criteria, neuroradiology examinations, and neurosurgical approaches to choose an effective and patient-tailored medical therapy. A multidisciplinary approach is particularly useful in difficult/aggressive acromegaly to schedule multimodal treatment, which includes radiation therapy, chemotherapy with temozolomide and other, recent emerging treatments. Herein, we describe the role of the different members of the multidisciplinary team according to our personal experience; a flow-chart for the therapeutic approach of difficult/aggressive acromegaly patients is proposed.

Bianchi, A., Chiloiro, S., Giampietro, A., Gaudino, S., Calandrelli, R., Mazzarella, C., Caldarella, C., Rigante, M., Gessi, M., Lauretti, L., De Marinis Grasso, L., Olivi, A., Pontecorvi, A., Doglietto, F., Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors, <<FRONTIERS IN ENDOCRINOLOGY>>, 2023; 14 (may 3): N/A-N/A. [doi:10.3389/fendo.2023.1123267] [https://hdl.handle.net/10807/272738]

Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors

Bianchi, Antonio;Chiloiro, Sabrina;Giampietro, Antonella;Gaudino, Simona;Calandrelli, Rosalinda;Caldarella, Carmelo;Rigante, Mario;Gessi, Marco;Lauretti, Liverana;De Marinis Grasso, Laura;Olivi, Alessandro;Pontecorvi, Alfredo;Doglietto, Francesco
2023

Abstract

Growth Hormone-secreting adenomas exhibits variable biological behavior and heterogeneous natural history, ranging from small adenomas and mild disease, to invasive and aggressive neoplasms with more severe clinical picture. Patients not cured or controlled after neurosurgical and first-generation somatostatin receptor ligands (SRL) therapy could require multiple surgical, medical and/or radiation treatments to achieve disease control. To date, no clinical, laboratory, histopathological, or neuroradiological markers are able to define the aggressiveness or predict the disease prognosis in patients with acromegaly. Therefore, the management of these patients requires careful evaluation of laboratory assessments, diagnostic criteria, neuroradiology examinations, and neurosurgical approaches to choose an effective and patient-tailored medical therapy. A multidisciplinary approach is particularly useful in difficult/aggressive acromegaly to schedule multimodal treatment, which includes radiation therapy, chemotherapy with temozolomide and other, recent emerging treatments. Herein, we describe the role of the different members of the multidisciplinary team according to our personal experience; a flow-chart for the therapeutic approach of difficult/aggressive acromegaly patients is proposed.
2023
Inglese
Bianchi, A., Chiloiro, S., Giampietro, A., Gaudino, S., Calandrelli, R., Mazzarella, C., Caldarella, C., Rigante, M., Gessi, M., Lauretti, L., De Marinis Grasso, L., Olivi, A., Pontecorvi, A., Doglietto, F., Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors, <<FRONTIERS IN ENDOCRINOLOGY>>, 2023; 14 (may 3): N/A-N/A. [doi:10.3389/fendo.2023.1123267] [https://hdl.handle.net/10807/272738]
File in questo prodotto:
File Dimensione Formato  
fendo-14-1123267.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.43 MB
Formato Adobe PDF
1.43 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/272738
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact